$NVO News

Novo Nordisk A/S Reports Share Repurchase Transactions Under DKK 15 billion Programme

Novo Nordisk A/S - share repurchase programme

Novo Nordisk's Awiqli Receives FDA Approval As The First And Only Once-Weekly Insulin For Children 10 Years Of Age And Older With Type 2 Diabetes

More Americans Now Take GLP-1 Drugs for Weight Loss Than Diabetes as Food, Alcohol and Apparel Habits Shift, Survey Finds

Novo Nordisk (CPSE:NOVO B) Deepens AI Drug Discovery Ties

Where Will Novo Stock Be in 10 Years?

Novo's CagriSema Delivered 25% Weight Loss in Women. Could It Help Turn Around the Beaten-Down Stock?

Novo Nordisk (NVO) Stock Sinks As Market Gains: Here's Why

Is Trending Stock Novo Nordisk A/S (NVO) a Buy Now?

Novo Nordisk A/S - share repurchase programme

Novo Nordisk (NVO) Could Be 63% Undervalued Following Its Share Buyback

Is Novo Nordisk (NYSE:NVO) A Long Term Value Opportunity Now?

Ablexis Announce License Agreement with Novo

Why Novo Nordisk (NVO) Dipped More Than Broader Market Today

Novo Down 11% in a Month: How Should Investors Approach the Stock Now?

BMO Capital Maintains Market Perform on Novo Nordisk, Lowers Price Target to $40

Novo Nordisk A/S - share repurchase programme

Bristol Myers Squibb vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

Novo Nordisk (NVO) Raised Its Outlook, Then Aimed for Average Growth

Citi Cuts Novo Nordisk Price Target to DKK 296 on Limited Margin Growth Outlook